A 47-year-old woman underwent orthotopic
liver transplantation (OLT) for hepatitis B virus (HBV)-related end-stage
liver cirrhosis. The patient received
hepatitis B immunoglobulin prophylaxis after OLT. Despite the protective level of the serum anti-
hepatitis-B surface antibody, HBV recurred at 22 months post-OLT and induced subacute
hepatic failure. The pre-OLT HBV genome contained a complex mutation pattern in overlapping frame regions of the surface (S) and polymerase (P) genes, which is the same mutation pattern as seen in post-OLT HBV
DNA. G145R and K141R mutations in the "a" determinant were detected only in the post-OLT sample.
Clevudine (30 mg once daily) was administered for recurrent
hepatitis B.
Hepatitis B was reactivated with a flare-up, and a M204I mutation (YIDD mutant type) appeared with a higher viral load at 9 months after
clevudine treatment. We report here a case of a YIDD mutation that developed in recurrent
hepatitis B after OLT induced by an S-escape mutant.